Changes of cerebral functional connectivity induced by foot reflexology in a RCT.

Autor: Descamps E; Inserm Unité ToNIC, UMR 1214, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024, Toulouse CEDEX 3, France. emeline.descamps@inserm.fr.; CNRS, Toulouse, France. emeline.descamps@inserm.fr., Boussac M; Inserm Unité ToNIC, UMR 1214, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024, Toulouse CEDEX 3, France. mathilde.boussac@inserm.fr., Joineau K; Inserm Unité ToNIC, UMR 1214, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024, Toulouse CEDEX 3, France., Payoux P; Inserm Unité ToNIC, UMR 1214, CHU PURPAN - Pavillon BAUDOT, Place du Dr Joseph Baylac, 31024, Toulouse CEDEX 3, France.

Publikováno v: Scientific reports [Sci Rep] 2023 Oct 10; Vol. 13 (1), pp. 17139. Date of Electronic Publication: 2023 Oct 10.

Botulinum Toxin for Axial Postural Abnormalities in Parkinson's Disease: A Systematic Review.

Autor: Gandolfi, Marialuisa^1,2,3 (AUTHOR) marialuisa.gandolfi@univr.it, Artusi, Carlo Alberto^4,5 (AUTHOR) caartusi@gmail.com, Imbalzano, Gabriele^4,5 (AUTHOR) gabriele.imbalzano@unito.it, Camozzi, Serena¹ (AUTHOR) mauro.crestani@univr.it, Crestani, Mauro¹ (AUTHOR), Lopiano, Leonardo^4,5 (AUTHOR) leonardo.lopiano@unito.it, Tinazzi, Michele¹ (AUTHOR) marialuisa.gandolfi@univr.it, Geroin, Christian⁶ (AUTHOR) christian.geroin@univr.it

Publikováno v: Toxins. May2024, Vol. 16 Issue 5, p228. 14p.

Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.

Autor: Brefel-Courbon C; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Centre, NS-PARK/FCRIN Network, Toulouse, France.; Toulouse Neuroimaging Centre (TONIC), UMR1214 INSERM/UT3, Toulouse, France., Harroch E; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Centre, NS-PARK/FCRIN Network, Toulouse, France., Marques A; Department of Neurology, CHU Clermont-Ferrand, Université Clermont-Auvergne, CNRS, IGCCN, Institut Pascal, NS-PARK/FCRIN Network, Aubière, France., Devos D; Department of Medical Pharmacology, Expert Centre of Parkinson's Disease, University of Lille, LilNCog, Lille Neuroscience and Cognition, Inserm, INSERM UMR-S1172, CHU de Lille LICEND COEN Center Lille NS-Park Network, Lille, France., Thalamas C; Department of Clinical Pharmacology, Methodology Data management and Statistical Analysis Unit, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France., Rousseau V; Department of Clinical Pharmacology, Methodology Data management and Statistical Analysis Unit, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France., Ory-Magne F; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Centre, NS-PARK/FCRIN Network, Toulouse, France., Fabbri M; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Centre, NS-PARK/FCRIN Network, Toulouse, France., Maltête D; Department of Neurology, Rouen University Hospital and University of Rouen, Mont-Saint-Aignan, France.; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, NS-PARK/FCRIN Network, Mont-Saint-Aignan, France., Rouaud T; Department of Neurology, Nantes University Hospital, NS-PARK/FCRIN Network, Nantes, France., Drapier S; Department of Neurology, Rennes University Hospital, CIC INSERM 1414, NS-PARK/FCRIN Network, Rennes, France., Tir M; Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson's Disease, Amiens University Hospital, EA 4559 Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP) Université de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), NS-PARK/FCRIN Network, Amiens, France., Thobois S; Univ Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, CNRS, Institut des Sciences Cognitives, UMR 5229, Bron, France.; Centre Expert Parkinson, Hôpital Neurologique 'Pierre Wertheimer', Hospices Civils de Lyon, NS-PARK/FCRIN Network, Lyon, France., Salhi H; Centre Expert Parkinson, Neurologie, and Equipe 01 NPI IMRB; CHU Henri Mondor, AP-HP, INSERM et Faculté de Santé, Université Paris-Est Créteil, Créteil, France., Corvol JC; Département de Neurologie, CIC Neurosciences, Sorbonne Université, Assistance Publique Hôpitaux de Paris, Paris Brain Institute (ICM), Inserm, CNRS, Hôpital Pitié-Salpêtrière, NS-PARK/FCRIN Network, Paris, France., Castelnovo G; Department of Neurology, CHU Nîmes, Hôpital Caremeau, Nimes, France., Lagha-Boukbiza O; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, NS-PARK/FCRIN Network, Strasbourg, France., Fluchère F; Service de Neurologie et Pathologie du Mouvement, Aix Marseille Université, AP-HM, Hôpital de La Timone, and UMR CNRS, Marseille, France., Frismand S; Neurology Department, Nancy University Hospital, Nancy, France., Ansquer S; Service de Neurologie, Centre Expert Parkinson, CIC-INSERM 1402, CHU Poitiers, NS-PARK/FCRIN Network, Poitiers, France., Sommet A; Department of Clinical Pharmacology, Methodology Data management and Statistical Analysis Unit, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France., Rascol O; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Centre, NS-PARK/FCRIN Network, Toulouse, France.; Toulouse Neuroimaging Centre (TONIC), UMR1214 INSERM/UT3, Toulouse, France.

Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Sep; Vol. 39 (9), pp. 1533-1543. Date of Electronic Publication: 2024 Jun 08.